Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
enoxaparin (lovenox) (1 trial)
gemcitabine (gemzar) (1 trial)
paclitaxel (taxol) (1 trial)
Adenocarcinoma (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Small Cell (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Trials (2 total)
Trial APIs (3 total)